Global healthcare group to realize our vision and maximize value
A vision-driven and value-generating global healthcare group.
Ildong Pharmaceutical Group was split into Ildong Holdings, Ildong Pharmaceutical, Ildong Bioscience, and Ildong Hyaltech in 2016 to achieve greater degrees of management specialization and efficiency.
Under this new group structure, Ildong Holdings, as the group’s holdings company, is responsible for supporting the group entities in their pursuit of realizing the group’s vision and generating value and for ensuring the continued growth of the group through the development of new businesses and the injection of fresh capital.
Ildong Holdings also facilitates collaboration amongst Ildong Pharmaceutical’s pharmaceutical interests, Ildong Bioscience’s probiotics and raw bio materials interests, Ildong Hyaltech’s hyaluronic acid interests, and the interests of other group entities to produce synergistic benefits across all facets of business, including sales and marketing.
With generating greater value for our customers and achieving ever higher levels of innovation and growth as the group’s goals for 2017 and with prioritization of quality, innovation of processes, and realization of positive earnings as specific actions that will help us reach those goals, every single member of Ildong Pharmaceutical Group is committed to a year of unprecedented achievements and progress.
Ildong Holdings shares the group’s philosophy of contributing to the health and happiness of humankind and continues to work towards growing as a sustainable and elite organization in pursuit of a balance between providing value to customers and realizing corporate profits.
|Company||Ildong Holdings Co., Ltd.|
|Founded||14 March 1941|
|Listing Date||23 June 1975 (securities listing)|
|Employees||72 (31 December 2016)|
|Main Business||Management of group affiliates and investing|